Cover Image
Annual Information Service

Malaysia Pharmaceuticals & Healthcare Q2 2020

Published by Fitch Solutions, Inc. Product code 179529
Published annual subscription Content info 72 Pages
Price
Back to Top
Malaysia Pharmaceuticals & Healthcare Q2 2020
Published: annual subscription Content info: 72 Pages
Description

Key View:

The Malaysian pharmaceutical market will experience robust growth over the coming years, driven by the country's

concerted effort to improve the health and well-being of its population. Driven by an ageing population, Malaysia's rising chronic

disease burden will be a key factor supporting demand for healthcare services and innovative medicines. However, the rising cost of

healthcare and elevated drug prices in Malaysia will see the government implement pharmaceutical price control measures given

the current lack of adequate regulation.

Table of Contents
Product Code: SSMY03_20200401

Table of Contents

  • Key View
  • SWOT
  • Industry Forecast
  • Pharmaceutical Market Forecast
  • Healthcare Market Forecast
  • Prescription Drug Market Forecast
  • Patented Drug Market Forecast
  • Generic Drug Market Forecast
  • OTC Medicine Market Forecast
  • Pharmaceutical Trade Forecast
  • Industry Risk/Reward Index
  • Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
  • Innovative Pharmaceuticals Risk/Reward Index
  • Regulatory Development
  • Regulatory Review
  • Market Overview

Competitive Landscape

  • Company Profile
  • Chemical Company Of Malaysia
  • Kotra Pharma
  • Novartis
  • Ranbaxy Malaysia
  • Sanofi
  • Malaysia Demographic Outlook
  • Pharmaceuticals & Healthcare Glossary
  • Pharmaceuticals & Healthcare Methodology
Back to Top